| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018672 |
| Receipt No. | R000020998 |
| Scientific Title | Histrogical factors in sinus tissue contributing to the prognosis of asthma in asthmatics cormobid with chronic sinusitis who underwent endoscopic sinus surgey |
| Date of disclosure of the study information | 2015/08/14 |
| Last modified on | 2019/04/01 (Ver. 6) |
| Basic information | ||
| Public title | Histrogical factors in sinus tissue contributing to the prognosis of asthma in asthmatics cormobid with chronic sinusitis who underwent endoscopic sinus surgey | |
| Acronym | The efficacy of endoscopic sinus surgey in patients with asthma | |
| Scientific Title | Histrogical factors in sinus tissue contributing to the prognosis of asthma in asthmatics cormobid with chronic sinusitis who underwent endoscopic sinus surgey | |
| Scientific Title:Acronym | The efficacy of endoscopic sinus surgey in patients with asthma | |
| Region |
|
|
| Condition | ||
| Condition | patients with asthma comorbid with chronic sinusitis
patients with chronic sinusitis healthy subjects |
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the association between histrogical indicies in sinus and the pathophygiology of asthma |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Associations of change in FEV1, asthma excerbation and control after surgey with historogical factors in sinus |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | If subjects meet the following criteria, they are eligible for this study. 1. Patients wiht chronic rhinosinusitis comorbid with or without asthma who are going to undergo endoscopic sinus surgey (FESS) 2. Age-matched healthy sujbect We will not collect sinus tissue from age-matched healthy subjects. |
|||
| Key exclusion criteria | Patients who undergo lobectomy after FESS, have comorbid with other respiratory disease such as chronic obstructive disease and interstitial pneumonitis, and are considered as ineligible for this study. Current smokers and ex-smokers of more than 10 pack-years were also excluded. |
|||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Nagoya City University School of Medical Sciences, Aichi, Japan. | ||||||
| Division name | Department of Respiratory Medicine, Allergy and Clinical Immunology | ||||||
| Zip code | 4678601 | ||||||
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan | ||||||
| TEL | 052-853-8216 | ||||||
| kaney32@med-nagoya-cu.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Nagoya City University School of Medical Sciences, Aichi, Japan. | ||||||
| Division name | Department of Respiratory Medicine, Allergy and Clinical Immunology | ||||||
| Zip code | 4678601 | ||||||
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan | ||||||
| TEL | 052-853-8216 | ||||||
| Homepage URL | |||||||
| kaney32@med.nagoya-cu.ac.jp | |||||||
| Sponsor | |
| Institute | Nagoya City University School of Medical Sciences, Aichi, Japan. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, |
| Address | 1 Kawasumi, Mizuho-Cho, Mizuho-Ku |
| Tel | 0528538216 |
| kaney32@med.nagoya-cu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Associations of changes in FEV1, the frequency of ashtma exacerbation, and asthma control 1 year after FESS with the pathological findings of sinus tissue are evaluated.
The difference in histological indices between CRS patients with or without asthma is also determined. Biomarkers such as blood eosinophils, serum IgE titiers against specific allergens and exhaled nitric oxide and FEV1 at baseline are compared among CRS patients with or without asthma and healthy subjects. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020998 |